BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17106439)

  • 1. Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study.
    Franceschi S; Polesel J; Rickenbach M; Dal Maso L; Probst-Hensch NM; Fux C; Cavassini M; Hasse B; Kofler A; Ledergerber B; Erb P; Clifford GM
    Br J Cancer; 2006 Dec; 95(11):1598-602. PubMed ID: 17106439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis virus B and C infections are associated with an increased risk of non-Hodgkin lymphoma: A nested case-control study using a national sample cohort.
    Kim M; Lee YK; Park B; Oh DJ; Choi HG
    J Med Virol; 2020 Aug; 92(8):1214-1220. PubMed ID: 31825111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma.
    Kuniyoshi M; Nakamuta M; Sakai H; Enjoji M; Kinukawa N; Kotoh K; Fukutomi M; Yokota M; Nishi H; Iwamoto H; Uike N; Nishimura J; Inaba S; Maeda Y; Nawata H; Muta K
    J Gastroenterol Hepatol; 2001 Feb; 16(2):215-9. PubMed ID: 11207904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus seroprevalence in patients with diffuse large B cell lymphoma and Hodgkin's lymphoma.
    Mert D; Merdin A; Ceken S; Dal MS; Ertek M; Altuntas F
    J Cancer Res Ther; 2021; 17(4):951-955. PubMed ID: 34528547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Franceschi S; Lise M; Trépo C; Berthillon P; Chuang SC; Nieters A; Travis RC; Vermeulen R; Overvad K; Tjønneland A; Olsen A; Bergmann MM; Boeing H; Kaaks R; Becker N; Trichopoulou A; Lagiou P; Bamia C; Palli D; Sieri S; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Peeters PH; Rodríguez L; Barroso LL; Dorronsoro M; Sánchez MJ; Navarro C; Barricarte A; Regnér S; Borgquist S; Melin B; Hallmans G; Khaw KT; Wareham N; Rinaldi S; Hainaut P; Riboli E; Vineis P
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):208-14. PubMed ID: 21098651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B and C virus infection in Romanian non-Hodgkin's lymphoma patients.
    Cucuianu A; Patiu M; Duma M; Basarab C; Soritau O; Bojan A; Vasilache A; Mates M; Petrov L
    Br J Haematol; 1999 Nov; 107(2):353-6. PubMed ID: 10583224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland.
    Zucca E; Roggero E; Maggi-Solcà N; Conconi A; Bertoni F; Reilly I; Castelli D; Pedrinis E; Piffaretti JC; Cavalli F
    Haematologica; 2000 Feb; 85(2):147-53. PubMed ID: 10681721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral genomes and antigen detection of hepatitis B and C viruses in involved lymph nodes of Egyptian non-Hodgkin's lymphoma patients.
    El-Sayed GM; Mohamed WS; Nouh MA; Moneer MM; El-Mahallawy HA
    Egypt J Immunol; 2006; 13(1):105-14. PubMed ID: 17974155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy.
    Talamini R; Montella M; Crovatto M; Dal Maso L; Crispo A; Negri E; Spina M; Pinto A; Carbone A; Franceschi S
    Int J Cancer; 2004 Jun; 110(3):380-5. PubMed ID: 15095303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study.
    Wang Q; De Luca A; Smith C; Zangerle R; Sambatakou H; Bonnet F; Smit C; Schommers P; Thornton A; Berenguer J; Peters L; Spagnuolo V; Ammassari A; Antinori A; Quiros-Roldan E; Mussini C; Miro JM; Konopnicki D; Fehr J; Campbell MA; Termote M; Bucher HC;
    Ann Intern Med; 2017 Jan; 166(1):9-17. PubMed ID: 27750294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of hepatitis B virus and hepatitis C virus infections in patients with Hodgkin's and non-Hodgkin's lymphoma.
    Kadry DY; Elbahnasawy MA; Mansour MT; El Gebaly OK; Aziz H; Kamel MM; Abdel-Moneim AS; Radwan S
    Int J Immunopathol Pharmacol; 2023; 37():3946320231207342. PubMed ID: 37859403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic viral hepatitis, HIV infection and Non-Hodgkin lymphomas in West Africa, a case-control study.
    Jaquet A; Boni SP; Boidy K; Tine J; Tchounga B; Touré SA; Koffi JJ; Dial C; Monnereau A; Diomande I; Tanon A; Seydi M; Dabis F; Diop S; Koffi G;
    Int J Cancer; 2021 Oct; 149(8):1536-1543. PubMed ID: 34124779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.
    Engels EA; Cho ER; Jee SH
    Lancet Oncol; 2010 Sep; 11(9):827-34. PubMed ID: 20688564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C infection is not associated with systemic HIV-associated non-Hodgkin's lymphoma: a cohort study.
    Waters L; Stebbing J; Mandalia S; Young AM; Nelson M; Gazzard B; Bower M
    Int J Cancer; 2005 Aug; 116(1):161-3. PubMed ID: 15756687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIV.
    Besson C; Noel N; Lancar R; Prevot S; Algarte-Genin M; Rosenthal E; Bonnet F; Meyohas MC; Partisani M; Oberic L; Gabarre J; Goujard C; Cheret A; Arvieux C; Katlama C; Salmon D; Boué F; Costello R; Hendel-Chavez H; Taoufik Y; Fontaine H; Coppo P; Mounier N; Delobel P; Costagliola D;
    AIDS; 2020 Mar; 34(4):599-608. PubMed ID: 31833850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of isolated antibody against core antigen of hepatitis B virus: association with HIV infection and age but not hepatitis C virus infection.
    Liang SH; Chen TJ; Lee SS; Tseng FC; Huang CK; Lai CH; Chiou CP; Wang JL; Chung HC; Lin JN; Kuo YC; Lin HH
    J Acquir Immune Defic Syndr; 2010 Jun; 54(2):122-8. PubMed ID: 20386111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.
    Polesel J; Clifford GM; Rickenbach M; Dal Maso L; Battegay M; Bouchardy C; Furrer H; Hasse B; Levi F; Probst-Hensch NM; Schmid P; Franceschi S;
    AIDS; 2008 Jan; 22(2):301-6. PubMed ID: 18097233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of Epstein-Barr virus, hepatitis B virus, hepatitis C virus, and human immunodeficiency virus among patients with non-Hodgkin's lymphoma at the Yaounde General Hospital, Cameroon.
    Bikoï JN; Ndedi EDFM; Okobalemba EA; Mbaga DS; Mikangue CAM; Membangbi AE; Nguiffo EM; Essindi JO; Mondinde GI; Essama SHR
    Pan Afr Med J; 2022; 42():58. PubMed ID: 35949454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
    Otegbayo JA; Taiwo BO; Akingbola TS; Odaibo GN; Adedapo KS; Penugonda S; Adewole IF; Olaleye DO; Murphy R; Kanki P
    Ann Hepatol; 2008; 7(2):152-6. PubMed ID: 18626434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea.
    Park SC; Jeong SH; Kim J; Han CJ; Kim YC; Choi KS; Cho JH; Lee M; Jung HH; Ki SS; Chang YH; Lee SS; Park YH; Lee KH
    J Med Virol; 2008 Jun; 80(6):960-6. PubMed ID: 18428141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.